Louisiana State Employees Retirement System Purchases Shares of 8,100 Addus HomeCare Corporation $ADUS

Louisiana State Employees Retirement System purchased a new position in Addus HomeCare Corporation (NASDAQ:ADUS) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 8,100 shares of the company’s stock, valued at approximately $759,000.

Other large investors have also made changes to their positions in the company. Royal Bank of Canada grew its position in Addus HomeCare by 24.3% during the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after buying an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Addus HomeCare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after buying an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Addus HomeCare by 6.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC raised its position in Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares in the last quarter. Finally, Intech Investment Management LLC lifted its stake in Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after purchasing an additional 4,439 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Transactions at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 966 shares of company stock valued at $90,168. Company insiders own 4.10% of the company’s stock.

Addus HomeCare Stock Down 0.2%

ADUS stock traded down $0.23 during midday trading on Tuesday, hitting $105.50. The company’s stock had a trading volume of 8,769 shares, compared to its average volume of 243,977. The stock has a market capitalization of $1.97 billion, a P/E ratio of 19.50, a PEG ratio of 1.44 and a beta of 0.88. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $124.43. The company’s fifty day moving average price is $95.33 and its 200 day moving average price is $101.15.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. The business had revenue of $363.50 million for the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.42 earnings per share. As a group, equities research analysts predict that Addus HomeCare Corporation will post 6.24 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ADUS. Weiss Ratings cut Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd. Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Barclays decreased their price objective on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $131.00.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.